Kenvue Inc. (KVUE)
NYSE
Closed
Aug 24, 2026
Day's Range
19.1352 wk Range
14.02Overview - KVUE - Kenvue Inc.
Key Statistics
Valuation
Enterprise Value
44.11B
P/E (Trailing)
‪22.42‬
P/E (Forward)
‪15.37‬
PEG Ratio
‪2.46‬
Price / Sales (TTM)
‪2.37‬
Price / Book
‪3.46‬
EV / EBITDA
‪12.67‬
Profitability
Gross Margin
‪58.17%‬
Profit Margin
‪10.76%‬
Operating Margin
‪19.41%‬
Return on Assets
‪6.99%‬
Return on Equity
‪15.58%‬
Ownership
Shares Outstanding
1.91B
Float
1.91B
Short % of Shares Outstanding
‪3.82%‬
Held by Insiders
‪0.07%‬
Held by Institutions
‪95.94%‬
Price stats
Beta
‪0.43‬
50-Day Avg
‪19.02‬
200-Day Avg
‪17.83‬
Dividends
Payout Ratio
‪97.65%‬
Frequency
Quarterly
Analyst Consensus
14 analysts
Average price target
‪$ 19.50‬Shariah Compliance
Report Date: Feb 20, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - KVUE - Kenvue Inc.
Peers - KVUE - Kenvue Inc.
Peer Comparison
Compared with companies in Household & Personal Products listed on NYSE.
Profile Summary - KVUE - Kenvue Inc.
About
Kenvue Inc. is a global consumer health company focused on over-the-counter medicines, personal care, and wellness products for everyday use. Headquartered in Summit, New Jersey, Kenvue develops and markets a broad portfolio of well-known brands across categories such as pain relief, allergy care, cough and cold,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
